A share price of Tandem Diabetes Care Inc [TNDM] is currently trading at $22.6, up 2.22%. In order to assess the stock’s recent performance, you can check whether its short-term value is rising or falling. The TNDM shares have gain 10.57% over the last week, with a monthly amount glided 21.44%, and seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Tandem Diabetes Care Inc [NASDAQ: TNDM] stock has seen the most recent analyst activity on December 16, 2025, when Robert W. Baird upgraded its rating to an Outperform but kept the price target unchanged to $30 for it. On September 08, 2025, Oppenheimer initiated with an Outperform rating and assigned a price target of $22 on the stock. Citigroup upgraded its rating to a Neutral but stick to its price target of $10.35 on August 12, 2025. Piper Sandler downgraded its rating to a Neutral but $14 remained the price target by the analyst firm on August 07, 2025. Citigroup downgraded its rating to Sell for this stock on July 09, 2025, but kept the price target unchanged to $14. In a note dated June 16, 2025, Truist initiated a Hold rating and provided a target price of $24 on this stock.
Tandem Diabetes Care Inc experienced fluctuations in its stock price throughout the past year between $9.98 and $38.28. Currently, Wall Street analysts expect the stock to reach $21.5 within the next 12 months. Tandem Diabetes Care Inc [NASDAQ: TNDM] shares were valued at $22.6 at the most recent close of the market. An investor can expect a potential drop of -4.87% based on the average TNDM price forecast.
Analyzing the TNDM fundamentals
Trailing Twelve Months sales for Tandem Diabetes Care Inc [NASDAQ:TNDM] were 1.01B which represents 2.17% growth. Gross Profit Margin for this corporation currently stands at 0.53% with Operating Profit Margin at -0.19%, Pretax Profit Margin comes in at -0.2%, and Net Profit Margin reading is -0.2%. To continue investigating profitability, this company’s Return on Assets is posted at -0.23, Equity is -1.19 and Total Capital is -0.32. Upon thorough examination of the company’s fundamental financial framework, it becomes apparent that the debt-to-equity ratio stands at 3.38.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 21.65 points at the first support level, and at 20.71 for the second support level. However, for the 1st resistance point, the stock is sitting at 24.02, and for the 2nd resistance point, it is at 25.45.
Ratios To Look Out For
To put it in perspective, the Current Ratio for Tandem Diabetes Care Inc [NASDAQ:TNDM] is 2.44. In addition, the Quick Ratio stands at 1.90 and the Cash Ratio stands at 0.36. Considering the valuation of this stock, the price to sales ratio is 1.52, the price to book ratio is 11.52.
Transactions by insiders
Recent insider trading involved Sheridan John F, PRESIDENT & CEO, that happened on Aug 11 ’25 when 10000.0 shares were purchased. EVP & CHIEF FINANCIAL OFFICER, Vosseller Leigh completed a deal on Aug 08 ’25 to buy 13720.0 shares. Meanwhile, EVP & Chief Operating Officer Kyrillos Jean-Claude bought 10538.0 shares on Mar 07 ’25.
